Insulin, Insulin Resistance, and Platelet Signaling in Diabetes

El Haouari, 2008, Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review, Blood Cells Mol Dis, 41, 119, 10.1016/j.bcmd.2008.02.010

Fleming, 2003, AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets, Thromb Haemost, 90, 863, 10.1160/TH03-04-0228

Randriamboavonjy, 2004, Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway, J Exp Med, 199, 347, 10.1084/jem.20030694

Grill, 1987, Studies of high and low insulin responders with the hyperglycemic clamp technique, Metabolism, 36, 1125, 10.1016/0026-0495(87)90238-1

King, 1988, Effects of exercise and lack of exercise on insulin sensitivity and responsiveness, J Appl Physiol, 64, 1942, 10.1152/jappl.1988.64.5.1942

Ishida, 1996, Effects of insulin on calcium metabolism and platelet aggregation, Hypertension, 28, 209, 10.1161/01.HYP.28.2.209

Rauchfuss, 2008, Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets, J Thromb Haemost, 6, 856, 10.1111/j.1538-7836.2008.02925.x

Hers, 2007, Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway, Blood, 110, 4243, 10.1182/blood-2006-10-050633

Algenstaedt, 1997, Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart, J Biol Chem, 272, 23696, 10.1074/jbc.272.38.23696

Ferreira, 2004, IRS-1 mediates inhibition of Ca2+ mobilization by insulin via the inhibitory G-protein Gi, J Biol Chem, 279, 3254, 10.1074/jbc.M305474200

Naseem, 2008, Unresolved roles of platelet nitric oxide synthase, J Thromb Haemost, 6, 10, 10.1111/j.1538-7836.2007.02802.x

Ji, 2007, beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90, Proc Natl Acad Sci USA, 104, 8839, 10.1073/pnas.0611416104

Gambaryan, 2008, NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity, J Thromb Haemost, 6, 1376, 10.1111/j.1538-7836.2008.03014.x

Suzuki, 2004, Structure, activation, and biology of calpain, Diabetes, 53, S12, 10.2337/diabetes.53.2007.S12

Kuchay, 2007, Calpain-mediated regulation of platelet signaling pathways, Curr Opin Hematol, 14, 249, 10.1097/MOH.0b013e3280ef68f8

Kuchay, 2007, Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets, Mol Cell Biol, 27, 6038, 10.1128/MCB.00522-07

Xi, 2006, Tyrosine phosphorylation of the integrin β3 subunit regulates β3 cleavage by calpain, J Biol Chem, 281, 29426, 10.1074/jbc.C600039200

Grant, 2007, Diabetes mellitus as a prothrombotic condition, J Intern Med, 262, 157, 10.1111/j.1365-2796.2007.01824.x

Crawford, 2008, Murine platelets are not regulated by O-linked β-N-acetylglucosamine, Arch Biochem Biophys, 474, 220, 10.1016/j.abb.2008.03.014

Trovati, 2002, Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function, J Diabetes Complications, 16, 35, 10.1016/S1056-8727(01)00196-9

Seghieri, 2001, Platelet antioxidant enzymes in insulin-dependent diabetes mellitus, Clin Chim Acta, 309, 19, 10.1016/S0009-8981(01)00494-6

Abe, 1997, c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1), J Biol Chem, 272, 20389, 10.1074/jbc.272.33.20389

Redondo, 2005, Ca2+-independent activation of Bruton's tyrosine kinase is required for store-mediated Ca2+ entry in human platelets, Cell Signal, 17, 1011, 10.1016/j.cellsig.2004.11.019

Yamaguchi, 1991, Platelet free Ca2+ concentration in non-insulin-dependent diabetes mellitus, Diabetes Res, 18, 89

Vangheluwe, 2005, Modulating sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) activity: cell biological implications, Cell Calcium, 38, 291, 10.1016/j.ceca.2005.06.033

Dean, 1997, Regulation of platelet plasma membrane Ca2+-ATPase by cAMP-dependent and tyrosine phosphorylation, J Biol Chem, 272, 15113, 10.1074/jbc.272.24.15113

Randriamboavonjy, 2008, Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and μ-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone, Circulation, 117, 52, 10.1161/CIRCULATIONAHA.107.719807

Gisinger, 1988, Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients: double-blind crossover trial, Diabetes, 37, 1260, 10.2337/diab.37.9.1260

Sacco, 2003, Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial, Diabetes Care, 26, 3264, 10.2337/diacare.26.12.3264

Worthley, 2007, The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes: mediation by superoxide production, resolution with intensive insulin administration, J Am Coll Cardiol, 49, 304, 10.1016/j.jacc.2006.08.053

Ishizuka, 1998, Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism, Diabetes, 47, 1494, 10.2337/diabetes.47.9.1494